Dr. Agarwal’s Health Care Limited announced that its Scheme of Amalgamation with Dr. Agarwal’s Eye Hospital Limited is now effective from November 1, 2026. The authorized share capital of Dr. Agarwal’s Health Care Limited will be altered, and a record date of November 18, 2026, has been fixed for determining eligible shareholders for the share exchange. This marks a significant step in the consolidation of the two entities.
Scheme of Amalgamation Becomes Effective
Dr. Agarwal’s Health Care Limited has confirmed that the Scheme of Amalgamation between itself and Dr. Agarwal’s Eye Hospital Limited has officially become effective from November 1, 2026. This follows the NCLT’s sanction order dated September 30, 2026, and the subsequent filing with the Registrar of Companies on October 15, 2026. The appointed date for the scheme remains April 01, 2026.
Alteration of Authorized Share Capital
As a consequence of the amalgamation becoming effective, the authorized share capital of Dr. Agarwal’s Health Care Limited has been altered. The existing share capital of Dr. Agarwal’s Eye Hospital Limited, comprising 2,00,00,000 Equity Shares of face value of ₹10 each, has been reclassified into 20,00,00,000 Equity Shares of face value of ₹1 each. This reclassified capital will be automatically combined and merged with the existing authorized share capital of Dr. Agarwal’s Health Care Limited.
Prior to the scheme’s effectiveness, the authorized share capital of Dr. Agarwal’s Health Care Limited was ₹90,00,00,000/-, consisting of 54,20,00,000 Equity shares of INR 1 each and 35,80,00,000 preference shares of INR 100 each. Post-effectiveness, the total authorized share capital will increase to ₹110,00,00,000/-, comprising 74,20,00,000 Equity shares of INR 1 each and the same preference share structure.
Record Date for Share Allotment
To facilitate the allotment of consideration shares to the eligible shareholders of the Transferor Company (Dr. Agarwal’s Eye Hospital Limited), a record date has been fixed. The Board of Directors, in consultation with the Transferor Company, has set Wednesday, November 18, 2026, as the Record Date. This date will determine which shareholders are entitled to receive consideration shares based on the approved Share Exchange Ratio. The ratio stipulates 23 (Twenty-Three) fully paid-up Equity Shares of face value of ₹1 each of Dr. Agarwal’s Health Care Limited for every 2 (Two) fully paid-up Equity Shares of face value of ₹10 each held in Dr. Agarwal’s Eye Hospital Limited.
Source: BSE
